Medicine & Healthcare Infectious disease

Dr Sarkar is a senior research fellow at the Murdoch Children's Research Institute in Melbourne, Australia. She is actively engaged in collaborating with academic and industry stakeholders and leads multiple projects for the development of novel therapeutics/vaccines to tackle antimicrobial resistance.

Dr. Ashfaq Ahmad Shah 'اشفاک,' born on 6 June 1992, from south Kashmir, Dodarkoot ددیرکوٹ Kulgam, Jammu and Kashmir, India, is the microbiologist whose broad area of specialization incorporates infection immunity. He served as a researcher at the Graphic Era (Deemed to be University), Dehradun, UK, India, from 2020 to 2025. Currently he is working as Postdoctoral researcher and Junior Scientist in the KIET School of Pharmacy at KIET University. As a microbiology scientist, Dr. Shah has pursued novel dimensions of infection immunity pertaining to the correlation and impact of elicitation-triggered phytoalexins and phytoanticipins on the benign immune system of human beings. This parameter of immunology is termed phytoalexin-immunomodulation scrutiny in the contemporary era. Dr. Shah's research encompasses a range of areas, including the indagation on anti-inflammatory and antimicrobial compounds, evaluation of antibiotic resistance, study of immunomodulatory activities, disease model studies, protease isolation against specific protein antigens, study of novel compounds via the hyphenated techniques of GCMS, HPLC, FTIR-MS, etc., and the discipline of kalology, including tyrosinase inhibition, PPO inhibition, skin whitening agents, kerato-peeling, etc. Dr. Ashfaq is a scientist, doctoral researcher, reviewer, and editorial member of several journals and books of national and international repute. He has contributed extensively to scientific literature by publishing his research in journals of national and international repute. So far he has published more than forty infection/immunology/pharmacology scientific papers in Scopus and SCI-indexed journals, including two international books. In recognition of his contributions, Dr. Shah received the Young Scientist Award in August 2023 for his groundbreaking academic performance in the field of infection immunity. Dr. Shah has also been an active editor of Wikipedia pages in the field of medical science since 2015, with more than 1000 edits in medical topics available to medical literature worldwide.

Dr. Singhal serves as senior principal investigator at the Bacterial Immunopathology Lab at A*STAR ID Labs in Singapore. His work at A*STAR ID Labs revolves around three main pathogens: Mycobacterium tuberculosis, Gram-negative bacteria and Dengue virus.

Professor St-Hilaire is a professor at the Department of Infectious Diseases and Public Health, City University of Hong Kong (CityU). She has extensively researched fish nutrition and diseases, including treatment efficacy, and has helped investigate fish disease outbreaks.

Dr. Van was previously the Director of the Research Institute for Aquaculture No.1 (RIA1) under Vietnam’s Ministry of Agriculture and Rural Development. She has extensive expertise in aquatic animal health and aquaculture safety management.

Dr. Dong currently works at the Asian Institute of Technology. He does research in Aquaculture, Pathology, Infectious Diseases, and Aquatic Bioscience.

Suraj Bhattarai is a global health specialist and tropical medicine physician with research interests in infectious disease epidemiology and surveillance, health systems, and urban health. He is a co-founder and research fellow at the Global Institute for Interdisciplinary Studies, a Kathmandu-based academic institute that promotes and conducts interdisciplinary research. He is a member of Global Young Academy and an Alumni steering committee member of IAP-Young Physician Leaders Programme. He obtained medical training in Nepal and masters in Tropical Medicine & International Health from the LSHTM, UK.

Prof. Tomoharu Yasuda's laboratory studies how immune system is regulated through the antigen receptor, intracellular signaling and lymphocyte programming.

Prof. Antonio Bertoletti's current research focuses on the development of new immunological based therapies (TCR-redirected T cells, HLA-peptide specific antibodies) for the treatment of HBV and Hepatocellular carcinoma (HCC), and the characterization of human intra-sinusoidal hepatic immune system.

Professor Linfa Wang is a Professor with the Emerging Infectious Diseases Programme at Duke-NUS Medical School, Singapore.

Associate Professor Sophia Archuleta is the Head and Senior Consultant of the Division of Infectious Diseases at the National University Hospital, Singapore.

Prof. Ashley St. John is an expert in viral immunology and emerging infectious diseases, such as dengue and Zika viruses. She heads the Laboratory of Immunity and Immune Pathology at Duke-NUS Medical School.